Company intelligence / Profile preview

MyMycoLab

Tampa Bay, Florida, United Statesmymycolab.com ↗

Ownership: Private
Development stage: Commercial

Overview

MyMycoLab offers a CLIA-certified blood serum antibody test panel for 14 different mycotoxins using both IgG and IgE detection. This approach is considered highly accurate and specific for diagnosing current exposure to toxic molds and related illnesses. The company provides results with detailed explanations and recommendations for clinicians. Their technology has been validated over two decades

Therapeutic areas: PulmonologyImmunologyInfectious Diseases
Modalities: Diagnostic test (blood serum antibody testing)
Industry: Protein Biomarker Diagnostics

Partnerships

Evexia Diagnostics

Beyond the preview

Go deeper on MyMycoLab.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MyMycoLab.

Explore the full profile